Brief: Esperion Reaches Settlement Agreement With ANDA Filer

Esperion Therapeutics

03/10/2025 13:08

Oct 3 (Reuters) - Esperion Therapeutics Inc ESPR.O:

ESPERION REACHES SETTLEMENT AGREEMENT WITH ANDA FILER, DR. REDDY’S LABORATORIES, NOT TO MARKET GENERIC VERSIONS OF NEXLETOL® (BEMPEDOIC ACID) AND NEXLIZET® (BEMPEDOIC ACID AND EZETIMIBE) PRIOR TO APRIL 19, 2040

ESPERION THERAPEUTICS - DR. REDDY'S AGREES NOT TO MARKET GENERIC NEXLETOL OR NEXLIZET BEFORE 2040

ESPERION THERAPEUTICS - PATENT LITIGATION AGAINST ALKEM, AUROBINDO PHARMA, MSN, RENATA, SANDOZ IS ONGOING

Source text: ID:nGNXbsJ3zY

Further company coverage: ESPR.O

 ((Reuters.Briefs@thomsonreuters.com;))